Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950129-06-002524
Filing Date
2006-03-13
Accepted
2006-03-10 20:41:22
Documents
9
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ENCYSIVE PHARMACEUTICALS INC.- DECEMBER 31, 2005 h33771e10vk.htm 10-K 708657
2 FOURTH AMENDMENT TO LEASE AGREEMENT h33771exv10w31.htm EX-10.31 18613
3 CODE OF ETHICS h33771exv14w1.htm EX-14.1 60504
4 SUBSIDIARIES OF THE REGISTRANT h33771exv21w1.htm EX-21.1 2281
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM h33771exv23w1.htm EX-23.1 2369
6 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) h33771exv31w1.htm EX-31.1 7825
7 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) h33771exv31w2.htm EX-31.2 7531
8 CERTIFICATION OF CEO PURSUANT TO SECTION 906 h33771exv32w1.htm EX-32.1 3065
9 CERTIFICATION OF CFO PURSUANT TO SECTION 906 h33771exv32w2.htm EX-32.2 3402
  Complete submission text file 0000950129-06-002524.txt   815792
Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081 7137968822
ENCYSIVE PHARMACEUTICALS INC (Filer) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20117 | Film No.: 06680746
SIC: 2834 Pharmaceutical Preparations